Learning from haematology

2 August 2017 0

Many of our most profound insights into the nature of cancer and its treatment have originated in the field of haematology. It was the high levels of bone marrow toxicity among soldiers who had been [more]

Many of our most profound insights into the nature of cancer and its treatment have originated in the field of haematology. It was the high levels of bone marrow toxicity among soldiers who had been exposed to mustard gas in in Wo... [ more ]

Haemato-oncology – Where precision medicine is finding its target

2 August 2017 0

With the prospect of a chemo-free cure for some blood cancers, and with new targets and new drugs emerging at an unprecedented pace, Simon Crompton asks: Is haematology where the promise of precision medicine will [more]

With the prospect of a chemo-free cure for some blood cancers, and with new targets and new drugs emerging at an unprecedented pace, Simon Crompton asks: Is haematology where the promise of precision medicine will finally be reali... [ more ]

A visionary who made a lasting contribution – Patrick Johnston, medical oncologist 1958–2017

2 August 2017 0

The European School of Oncology has lost a supporter, colleague and friend, writes Mike Clarke, who co-chaired ESO’s Systematic Reviews Masterclass alongside Patrick Johnston. With the sudden and unexpected death of Patrick Johnston on 4 [more]

The European School of Oncology has lost a supporter, colleague and friend, writes Mike Clarke, who co-chaired ESO’s Systematic Reviews Masterclass alongside Patrick Johnston.... [ more ]

Prevention and early detection – If we don’t prioritise them, why should anyone else?

2 August 2017 1

Oncology is understandably fascinated by ideas around precision treatment. As a medical oncologist who was there when the germs of this approach first appeared 50 years ago, I do of course share the excitement over [more]

Oncology is understandably fascinated by ideas around precision treatment. As a medical oncologist who was there when the germs of this approach first appeared 50 years ago, I do of course share the excitement over the news that c... [ more ]

Josep Tabernero ESMO President Elect

2 August 2017 0

Josep Tabernero is active at many levels. He does hands-on translational research in the lab and clinic, he directs one of Europe’s top cancer institutes, and he will shortly be taking over the leadership of [more]

Josep Tabernero is active at many levels. He does hands-on translational research in the lab and clinic, he directs one of Europe’s top cancer institutes, and he will shortly be taking over the leadership of the European Society... [ more ]

Lisa Hutchinson: teasing out the signal from the noise

2 August 2017 0

The explosion of new information in the era of personalised medicine has created a headache for busy clinicians. Lisa Hutchinson has spent the past 13 years helping them keep abreast of developments by sifting, sorting [more]

The explosion of new information in the era of personalised medicine has created a headache for busy clinicians. Lisa Hutchinson has spent the past 13 years helping them keep abreast of developments by sifting, sorting and summari... [ more ]

Use of PARP inhibitors in ovarian cancer

2 August 2017 0

PARP inhibitors are the first class of drugs to exploit a new concept in oncology – synthetic lethality. Alexandra Leary explains the rationale, reviews the trial evidence and clinical experience, and looks to their future [more]

PARP inhibitors are the first class of drugs to exploit a new concept in oncology – synthetic lethality. Alexandra Leary explains the rationale, reviews the trial evidence and clinical experience, and looks to their future possibl... [ more ]

Do I refer this patient on? European family doctors swap notes on how they decide who should be tested for cancer

2 August 2017 0

Symptomatic cancers are diagnosed quicker in some countries than others. A group of European primary care physicians recently set out to discover why this is, by gathering information about the different factors that influence decision-making. [more]

Symptomatic cancers are diagnosed quicker in some countries than others. A group of European primary care physicians recently set out to discover why this is, by gathering information about the different factors that influence dec... [ more ]

Improving early diagnosis of symptomatic cancer

2 August 2017 0

Focusing on the UK situation, Willie Hamilton and colleagues investigate why speeding up diagnosis of symptomatic cancers may be important, how to achieve it, who to focus on and where, and finally how much such [more]

Focusing on the UK situation, Willie Hamilton and colleagues investigate why speeding up diagnosis of symptomatic cancers may be important, how to achieve it, who to focus on and where, and finally how much such strategies could c... [ more ]

Does being a patient have to be a full-time job?

2 August 2017 0

Most doctors believe in holistic care, yet the clinical guidelines they use, and the way they discuss and deliver care, rarely take into account the demands that a given treatment option will make on the [more]

Most doctors believe in holistic care, yet the clinical guidelines they use, and the way they discuss and deliver care, rarely take into account the demands that a given treatment option will make on the patient and their daily li... [ more ]
UA-77507851-1